← Back
$URGN All transactions

UroGen Pharma Ltd.

M

$ Value

Shares

10,000

Price

Filed

Jun 11

Insider

Name

Schoenberg Mark

Title

Chief Medical Officer

CIK

0001763581

Roles

Officer

Transaction Details

Transaction Date

2025-06-08

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

158,540

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. | Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. | The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.

Filing Info

Accession No.

0001437749-25-020045

Form Type

4

Issuer CIK

0001668243

Schoenberg Mark's History

Date Ticker Type Value
2026-02-03 URGN $36K
2026-02-03 URGN $36K
2026-02-03 URGN $73K
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN A $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Degnan Chris
Chief Financial Officer
2026-01-31
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$147K 2026-02-03